Matthias Oelke

Summary

Affiliation: Hannover Medical School
Country: Germany

Publications

  1. doi request reprint [Pharmacological treatment of benign prostatic hyperplasia]
    M Oelke
    Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland
    Urologe A 48:1365-75; quiz 1376-7. 2009
  2. ncbi request reprint Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials
    Matthias Oelke
    Department of Urology, Hannover Medical School, Carl Neuberg Str 1, 30625, Hannover, Germany
    World J Urol 31:1093-104. 2013
  3. doi request reprint Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial
    Matthias Oelke
    Department of Urology, Hannover Medical School, Hannover, Germany
    Eur Urol 61:917-25. 2012
  4. doi request reprint Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011
    Matthias Oelke
    Department of Urology, Hannover Medical School, Hannover, Germany
    Neurourol Urodyn 31:322-6. 2012
  5. pmc The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia
    Charalampos Mamoulakis
    Department of Urology, University of Crete Medical School, Heraklion, Crete, Greece
    World J Urol 29:199-204. 2011
  6. pmc Manual versus automatic bladder wall thickness measurements: a method comparison study
    Matthias Oelke
    Department of Urology and Urologic Oncology, Hannover Medical School, Carl Neuberg Str 1, 30625 Hannover, Germany
    World J Urol 27:747-53. 2009
  7. ncbi request reprint Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men
    Matthias Oelke
    Department of Urology, Medical School Hannover, Germany
    World J Urol 19:443-52. 2002
  8. ncbi request reprint [Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results]
    M Oelke
    Klinik und Poliklinik für Urologie und Kinderurologie, Medizinische Hochschule, Carl Neuberg Strasse 1, 30625 Hannover
    Urologe A 41:425-41. 2002
  9. doi request reprint [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management]
    M Oelke
    Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Carl Neuberg Strase 1, 30625, Hannover, Deutschland
    Urologe A 50:1257-8, 1260-4. 2011
  10. pmc Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study
    Matthias Oelke
    Department of Urology, Hannover Medical School, Carl Neuberg Str 1, 30625, Hannover, Germany
    World J Urol 29:217-23. 2011

Detail Information

Publications44

  1. doi request reprint [Pharmacological treatment of benign prostatic hyperplasia]
    M Oelke
    Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland
    Urologe A 48:1365-75; quiz 1376-7. 2009
    ..The combination of alpha-blocker plus 5alpha-reductase inhibitor can reduce LUTS and disease progression more effectively than single drugs...
  2. ncbi request reprint Review on ultrasound measurement of bladder or detrusor wall thickness in women: techniques, diagnostic utility, and use in clinical trials
    Matthias Oelke
    Department of Urology, Hannover Medical School, Carl Neuberg Str 1, 30625, Hannover, Germany
    World J Urol 31:1093-104. 2013
    ....
  3. doi request reprint Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial
    Matthias Oelke
    Department of Urology, Hannover Medical School, Hannover, Germany
    Eur Urol 61:917-25. 2012
    ..Tadalafil improved lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH; LUTS/BPH) in clinical studies but has not been evaluated together with an active control in an international clinical study...
  4. doi request reprint Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011
    Matthias Oelke
    Department of Urology, Hannover Medical School, Hannover, Germany
    Neurourol Urodyn 31:322-6. 2012
    ..Research proposals to further enlighten these associations were to be defined...
  5. pmc The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia
    Charalampos Mamoulakis
    Department of Urology, University of Crete Medical School, Heraklion, Crete, Greece
    World J Urol 29:199-204. 2011
    ..The aim of this retrospective study was to evaluate in a historical series of patients whether morphological changes of the urinary tract imaged on intravenous urography (IVU) are associated with clinical or urodynamic data...
  6. pmc Manual versus automatic bladder wall thickness measurements: a method comparison study
    Matthias Oelke
    Department of Urology and Urologic Oncology, Hannover Medical School, Carl Neuberg Str 1, 30625 Hannover, Germany
    World J Urol 27:747-53. 2009
    ..To compare repeatability and agreement of conventional ultrasound bladder wall thickness (BWT) measurements with automatically obtained BWT measurements by the BVM 6500 device...
  7. ncbi request reprint Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men
    Matthias Oelke
    Department of Urology, Medical School Hannover, Germany
    World J Urol 19:443-52. 2002
    ..BOO is found in 95.5% of men with a detrusor wall thickness greater than or equal to 2 mm. Measuring the thickness of the detrusor wall can be used as a screening test to detect BOO...
  8. ncbi request reprint [Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results]
    M Oelke
    Klinik und Poliklinik für Urologie und Kinderurologie, Medizinische Hochschule, Carl Neuberg Strasse 1, 30625 Hannover
    Urologe A 41:425-41. 2002
    ....
  9. doi request reprint [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management]
    M Oelke
    Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Carl Neuberg Strase 1, 30625, Hannover, Deutschland
    Urologe A 50:1257-8, 1260-4. 2011
    ..Despite several epidemiological and clinical investigations on BPH disease progression no official programme exists in Germany for disease prevention...
  10. pmc Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study
    Matthias Oelke
    Department of Urology, Hannover Medical School, Carl Neuberg Str 1, 30625, Hannover, Germany
    World J Urol 29:217-23. 2011
    ..d. in the treatment of male OAB administered as monotherapy (MT) or add-on to α-blockers (combination treatment, CT) in relation to maximum urinary flow (Q(max)) in a non-interventional study...
  11. doi request reprint International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy
    Matthias Oelke
    Department of Urology, Hannover Medical School, Hannover, Germany
    Neurourol Urodyn 29:634-9. 2010
    ..Quantification of bladder wall hypertrophy seems to be useful for the assessment of diseases, prediction of treatment outcomes, and longitudinal studies investigating disease development and progression...
  12. doi request reprint [Is medical therapy useful in the management of stress urinary incontinence?]
    M Oelke
    Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule, Carl Neuberg Strasse 1, 30625 Hannover
    Urologe A 48:228-32. 2009
    ..Furthermore, duloxetine could be useful in women to support pelvic floor physiotherapy or in female patients awaiting incontinence surgery...
  13. ncbi request reprint Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies
    Hartmut Porst
    Department of Urology, Hannover Medical School, Hannover, Germany
    Urology 82:667-73. 2013
    ....
  14. doi request reprint EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction
    Matthias Oelke
    Department of Urology, Hannover Medical School, Hannover, Germany
    Eur Urol 64:118-40. 2013
    ..To present a summary of the 2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS)...
  15. doi request reprint Phosphodiesterase inhibitors in clinical urology
    Stefan Uckert
    Department of Urology and Urological Oncology, Division of Surgery, Hannover Medical School, Hannover, Germany
    Expert Rev Clin Pharmacol 6:323-32. 2013
    ....
  16. doi request reprint Insertion sheaths prevent breakage of flexible ureteroscopes due to laser fiber passage: a video-endoluminal study of the working channel
    Thomas R W Herrmann
    Department of Urology and Uro Oncology, Hannover Medical School MHH, Hannover, Germany
    J Endourol 24:1747-51. 2010
    ....
  17. ncbi request reprint Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
    Knut Albrecht
    Hannover Medical School, Deparment of Legal Medicine, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    J Forensic Leg Med 14:270-4. 2007
    ....
  18. doi request reprint Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction
    Thomas R W Herrmann
    Department of Urology and Urological Oncology, Hannover Medical School, Carl Neuberg Str 1, 30625 Hannover, Germany
    World J Urol 28:45-51. 2010
    ....
  19. ncbi request reprint Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data
    T R W Herrmann
    Department of Urology, Hannover Medical School, Carl Neuberg Str 1, 30625 Hannover, Germany
    Minerva Urol Nefrol 61:309-24. 2009
    ..The laser hybrid therapy with CLAP/visual laser ablation of the prostate (VLAP)/Nd:YAG was inferior to TURP. VLAP and KTP showed inhomogeneous..
  20. ncbi request reprint [Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia]
    H Tezval
    Klinik für Urologie und Uroonkologie, Medizinische Hochschule, Hannover, Deutschland
    Urologe A 47:1079-80, 1082-4. 2008
    ..However, CRFR2 expression in human benign prostatic tissue remains unknown. Our study therefore aimed to investigate CRFR2 expression in prostatic tissue...
  21. ncbi request reprint [The relevance of urinary bladder filling in suprapubic bladder catheterization]
    K Albrecht
    Institut fur Rechtsmedizin, Medizinische Hochschule Hannover, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Urologe A 43:178-84. 2004
    ..Based on our measurements, we recommend a preoperative bladder filling of > or =300 ml for an uncomplicated insertion of a suprapubic catheter...
  22. ncbi request reprint Historical aspects of the treatment of urinary incontinence
    D Schultheiss
    Department of Urology, Hannover Medical School, Hannover, Germany
    Eur Urol 38:352-62. 2000
    ....
  23. doi request reprint Pharmacologic characterization of human male urethral smooth muscle: an in vitro approach
    George T Kedia
    Division of Surgery, Department of Urology and Urological Oncology, Hannover Medical School, Hannover, Germany Electronic address
    Urology 82:1451.e13-9. 2013
    ..To elucidate the functional responses of isolated human urethral smooth muscle to various agents known to exert smooth muscle contraction or relaxation...
  24. doi request reprint Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostate
    Stefan Uckert
    Division of Surgery, Department of Urology and Urological Oncology, Hannover Medical School, 30625, Hannover, Germany
    World J Urol 31:609-14. 2013
    ..Hence, the significance of the nitric oxide (NO)/cyclic GMP signaling in the control of the human prostate requires further clarification...
  25. doi request reprint Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels
    Stefan Uckert
    Hannover Medical School, Division of Surgery, Department of Urology and Urological Oncology, Hannover, Germany
    Eur J Obstet Gynecol Reprod Biol 169:283-6. 2013
    ..5 (pgp 9.5)...
  26. doi request reprint Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older
    Richard Berges
    Department of Urology, PAN Klinik, Zeppelinstr 1, 50667, Cologne, Germany
    World J Urol 29:171-8. 2011
    ..These community-derived values of healthy older men are necessary to correctly judge patients with lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH)...
  27. ncbi request reprint Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice
    Matthias Oelke
    Hannover Medical School, Hannover, Germany
    BJU Int 110:710-8. 2012
    ..This paper will improve the consistency of treatment approaches for adult males with LUTS by providing a clear, concise summary of existing treatment guidelines that can be easily adopted by urologists and primary care specialists...
  28. doi request reprint Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms
    Claudius Fullhase
    Department of Urology, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    Eur Urol 64:228-43. 2013
    ..The combination of different compounds, each of which targets a different aspect of LUTS, seems appealing. However, only few clinical trials have evaluated the effects of combination therapies...
  29. doi request reprint Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011
    Ruth Kirschner-Hermanns
    Department of Urology, Continence Clinic, Aachen University Clinic RWTH, Aachen, Germany
    Neurourol Urodyn 31:359-64. 2012
    ..The purpose of this ICS-RS report is to highlight clinical and basic research data to outline directions for further research and possible treatment approaches...
  30. ncbi request reprint Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves
    Stefan Uckert
    Department of Urology, Hannover Medical School, Hannover, Germany
    Urology 65:604-10. 2005
    ..Nitric oxide and VIP, mediating biologic signals through cGMP and cAMP, have been assumed to be involved in the control of vaginal smooth muscle...
  31. ncbi request reprint Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms
    Matthias Oelke
    Hannover Medical School, Department of Urology, Hannover, Germany
    Expert Opin Drug Saf 13:1187-97. 2014
    ..Their adverse events (AEs) include asthenia, dizziness, nasal congestion, arterial (orthostatic) hypotension and intraoperative floppy iris syndrome (IFIS)...
  32. pmc Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction
    Stefan Uckert
    Hannover Medical School, Division of Surgery, Department of Urology and Urological Oncology, Hannover, Germany
    Br J Clin Pharmacol 72:197-204. 2011
    ..The strategy of modulating the activity of PDE isoenzymes might represent a novel approach in patients with lower urinary tract dysfunction (LUTD)...
  33. ncbi request reprint Immunohistochemical description of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human labia minora
    Stefan Uckert
    Hannover Medical School Department of Urology, Hannover, Germany
    J Sex Med 4:602-8. 2007
    ..Some findings indicated that there might be a significance of cyclic nucleotide-mediated pathways in the control of the normal function of female genital tissues...
  34. ncbi request reprint Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues
    Stefan Uckert
    Hannover Medical School Department of Urology, Hannover, Germany, and IPF Pharmaceuticals GmbH Urological Research Unit, Hannover, Germany
    J Sex Med 4:1604-9. 2007
    ..The elevated expression of PDE5 in the human penile erectile tissue is considered the reason for the high clinical efficacy of PDE5 inhibitors in the pharmacotherapy of male erectile dysfunction...
  35. ncbi request reprint Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate
    Stefan Uckert
    Hannover Medical School, Department of Urology, Hannover, Germany
    Eur Urol 49:740-5. 2006
    ..The aim of the present study was to evaluate by means of immunohistochemistry the expression and distribution of some cAMP- and cGMP-PDE isoenzymes in the prostate...
  36. ncbi request reprint In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors
    Stefan Uckert
    Department of Urology, Hannover Medical School, Carl Neuberg Str 1, 30625, Hannover, Germany
    World J Urol 23:398-404. 2005
    ..This might be of significance with regard to the pharmacological treatment of disorders connected with female sexual arousal and the ability to achieve orgasm...
  37. ncbi request reprint Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study
    Matthias Oelke
    Department of Urology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
    Urology 67:1111-6. 2006
    ..We sought to elucidate the presence of the phosphodiesterase (PDE) isoenzymes 3, 4, and 5 in the human clitoris using immunohistochemical and molecular biology methods...
  38. ncbi request reprint Ultrasound measurement of detrusor wall thickness in healthy adults
    Matthias Oelke
    Department of Urology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Neurourol Urodyn 25:308-17; discussion 318. 2006
    ..The aim of this study was to determine DWT in healthy adults and to investigate if bladder filling, gender, age, or body-mass index (BMI) influences DWT...
  39. ncbi request reprint Clinical relevance of urodynamic investigation tests prior to surgical correction of genital prolapse: a literature review
    Jan Paul W R Roovers
    Department of Obstetrics and Gynaecology, Academic Medical Centre, University of Amsterdam, Room H4 205, P O Box 22700, 1105 DE, Amsterdam, The Netherlands
    Int Urogynecol J Pelvic Floor Dysfunct 18:455-60. 2007
    ..This review presents a literature overview of what has been proven about the diagnostic and therapeutic value of urodynamic investigations in patients undergoing prolapse surgery...
  40. ncbi request reprint Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume
    Matthias Oelke
    Department of Urology, Academic Medical Center, University of Amsterdam, The Netherlands
    Eur Urol 52:827-34. 2007
    ....
  41. ncbi request reprint Drug-induced urinary incontinence
    Peter Tsakiris
    Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Drugs Aging 25:541-9. 2008
    ..However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes...
  42. doi request reprint Bladder wall thickness in healthy school-aged children
    Matthias Oelke
    Urology 72:233-4; author reply 234-5. 2008